Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Makoto Sakumoto is active.

Publication


Featured researches published by Makoto Sakumoto.


Operations Research Letters | 1993

Subdural hematoma associated with dural metastasis from paranasal sinus cancer: a case report and review of the literature.

Ikuo Nagayama; Hideaki Katoh; Makoto Sakumoto; Makoto Itoh; Kazuhiko Yoshida

We report a 72-year-old woman who developed a subdural hematoma following dural metastasis from paranasal sinus carcinoma. Subdural hematoma with malignant neoplasm is a serious condition seen only in advanced stages. The prognosis is poor, but appropriate measures can help the patient. Head and neck surgeons should note this unusual clinical entity.


Auris Nasus Larynx | 1996

Olfactory Evoked Potentials Produced by Electrical Stimulation of the Olfactory Mucosa

Tadashi Ishimaru; Makoto Sakumoto; Yasuyuki Kimura; Mitsuru Furukawa

We stimulated the olfactory mucosa electrically and elicited evoked potentials in rabbits. A bipolar stimulating electrode was placed on the olfactory region of the nasal mucosa via an anterior naris non-invasively. Evoked potentials were detected from the surface of a head. In most instances they were composed of triphasic negative-positive-negative peaks, the latencies of these peaks were about 25, 40, and 65 ms, respectively. This peak complex seemed to originate in the olfactory bulb. This method is non-invasive and is applicable to studying the olfactory system in animals and also in humans.


Operations Research Letters | 1989

Epstein-Barr Virus (EBV) Infection by Cocultivation of Fibroblast-Dominant Cell Line and EBV-Transformed Lymphocytes

M. Furukawa; Michihiro Kamide; Takaki Miwa; Makoto Sakumoto; Ryozo Umeda

A long-term cell culture epitheloid cell line (NPC-F/L) was established from the fibroblast-dominant cell line derived from nasopharyngeal carcinoma tissue by cocultivation with an Epstein-Barr virus (EBV)-transformed lymphoblastoid cell line of adenoid origin. The cells were investigated by karyotyping, by immunofluorescent testing for EBV-associated nuclear antigen (EBNA), early antigen (EA), and viral capsid antigen (VCA) and by a light microscopy. The cells were shown to be epithelial not only by morphology but also by immunocytochemical staining with monoclonal antibody to cytokeratins and they expressed EBNA and EA but not VCA. The cells developed histologically undifferentiated squamous cell carcinoma when inoculated subcutaneously into the back of athymic nude BALB/c(nu/nu) mice, which were similar to the human tumors from which the fibroblastoid cell line was established. The presence of EBNA in touch smears prepared both from the biopsy tissue of human and nude mice was demonstrated. Karyotyping analysis indicated an aneuploid chromosome with a model number of 74.


Practica oto-rhino-laryngologica | 1994

Acute Hearing Loss, 6000 Hz-dip Type; A Case Report.

Tadashi Ishimaru; Makoto Sakumoto; Ikuo Nagayama; Mitsuru Furukawa

We usually use 6 frequencies, 250, 500, 1000, 2000, 4000 and 8000 Hz, in conventional pure tone audiometry. When these 6 points do not show hearing loss, our clinical diagnosis is no hearing loss. If the hearing loss is not located in the clinical 6 frequencies, we cannot detect it.The authors diagnosed 6000 Hz-dip type acute hearing loss in a 43-year-old male with tinnitus. We measured the hearing levels at 6 frequencies and found no hearing loss. The pitch of his tinnitus was 6000 Hz, so we measured the hearing levels at 4 other frequencies (800, 1500, 3000 and 6000 Hz) and detected a 6000 Hz-dip.Steroid treatment cured both the tinnitus and the 6000 Hz-dip hearing loss.When hearing loss occurs at a frequency other than the conventional pure tone audiometric frequencies, a mistaken diagnosis of no hearing loss is made. If the patient complains of tinnitus, the clinician should investigate the pitch and measure the hearing level near the frequency of the tinnitus. This is a useful method of discovering narrow diptype acute hearing loss.


Chemical Senses | 1997

Olfactory evoked potential produced by electrical stimulation of the human olfactory mucosa

Tadashi Ishimaru; Takefumi Shimada; Makoto Sakumoto; Takaki Miwa; Yasuyuki Kimura; Mitsuru Furukawa


Nippon Jibiinkoka Gakkai Kaiho | 1990

EVALUATION OF TURNOVER OF OLFACTORY EPITHELIUM IN MICE BY USING ANTI-BRDU MONOCLONAL ANTIBODY

Yasuyuki Kimura; Michihiro Kamide; Mitsuru Furukawa; Takaki Miwa; Makoto Sakumoto; Ryouzo Umeda


Nippon Jibiinkoka Gakkai Kaiho | 1989

EXPERIMENTAL STUDY ON THE EFFECT OF THE TOPICAL APPLICATION OF STEROIDS BY THE OLFACTORY DISTURBANCE IN MICE

Yasuyuki Kimura; M. Furukawa; Michihiro Kamide; Makoto Sakumoto; Takaki Miwa; Ryozo Umeda


Practica oto-rhino-laryngologica | 1998

Efficacy of Emedastine Difumarate(DAREN) for Sever Perennial Allergic Rhinitis.

Tadashi Ishimaru; Takaki Miwa; Takeo Donjo; Makoto Sakumoto; Toshiro Nisjomura; Saichiro Tanaka; Nobuyuki Yachi; Satoshi Nishigouri; Shigeyuki Murono; Tomokazu Yoshizaki; Naohiro Wakisaka; Shigeru Ishikawa; Hideo Sakashita; Mitsuru Furukawa


Practica oto-rhino-laryngologica | 1997

Effects of Ambroxol on the Transfer of Ceftizoxime into the Ethmoid Cell Mucosa.

Takaki Miwa; Keiko Kita; Akiko Tamori; Akiko Nakahashi; Makoto Sakumoto; Yasuyuki Kimura; Yohzo Okabe; Ikuo Nagayama; Mitsuru Furukawa


Practica oto-rhino-laryngologica | 1995

Japanese Cedar Pollen Counts at Seven Observation Sites in Ishikawa Prefecture

Makoto Sakumoto; Saori Kikuchi; Naoki Uramoto; Ikuo Nagayama; Mitsuru Furukawa

Collaboration


Dive into the Makoto Sakumoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Takaki Miwa

Kanazawa Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge